QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clarivate-launches-ip-collaboration-hub-to-streamline-global-ip-management

 Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched the IP Collaboration Hub™ ...

 clarivate-inks-pact-with-healthwise-data-to-boost-real-world-data-offering-collaboration-enhances-patient-demographics-insight-enabling-analytical-precision-in-population-health-outcomes

Clarivate announced a strategic partnership with HealthWise Data, a leading healthcare data and analytics firm bridging the gap...

 why-is-clarivate-stock-trading-higher-premarket-monday

Clarivate Plc launched AI-enhanced Trademark Watch Analyzer at 2024 International Trademark Association Annual Meeting, connect...

 clarivate-debuts-ai-enhanced-solution-to-accelerate-trademark-watching-at-inta-2024

Providing faster and more accurate answers to critical business questions LONDON, May 20, 2024 /PRNewswire/ -- Clarivate Plc (...

 goldman-sachs-maintains-buy-on-clarivate-lowers-price-target-to-75

Goldman Sachs analyst George Tong maintains Clarivate (NYSE:CLVT) with a Buy and lowers the price target from $8.5 to $7.5.

 clarivate-q1-2024-gaap-eps-014-inline-sales-621200m-beat-614860m-estimate

Clarivate (NYSE:CLVT) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 22.22 ...

 clarivate-unveils-epidemiology-intelligence-for-precision-patient-population-analysis

Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for p...

 clarivate-enhances-cortellis-cmc-intelligence-with-post-approval-module-to-accelerate-regulatory-success

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly en...

 clarivate-joins-united-nations-sustainable-development-goals-un-sdgs-publishers-compact

 Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed the United ...

 analytics-firm-clarivate-acquires-ai-start-up-motionhall---whats-on-the-cards

Clarivate has agreed to acquire the majority of assets of MotionHall, a Silicon Valley technology start-up. MotionHall serves l...

 exor-amplifies-stake-in-clarivate-proposes-new-board-member

Exor N.V. increases stake in Clarivate Plc to 10.1%, with potential to reach 17.5%. Suzanne Heywood to join board, showing stro...

 morgan-stanley-maintains-equal-weight-on-clarivate-lowers-price-target-to-8

Morgan Stanley analyst Toni Kaplan maintains Clarivate (NYSE:CLVT) with a Equal-Weight and lowers the price target from $9 t...

 barclays-maintains-underweight-on-clarivate-lowers-price-target-to-6

Barclays analyst Manav Patnaik maintains Clarivate (NYSE:CLVT) with a Underweight and lowers the price target from $7 to $6.